DK1715755T3 - Anvendelse af levende bakterier til fremme af vækst i dyr - Google Patents

Anvendelse af levende bakterier til fremme af vækst i dyr Download PDF

Info

Publication number
DK1715755T3
DK1715755T3 DK05706458.6T DK05706458T DK1715755T3 DK 1715755 T3 DK1715755 T3 DK 1715755T3 DK 05706458 T DK05706458 T DK 05706458T DK 1715755 T3 DK1715755 T3 DK 1715755T3
Authority
DK
Denmark
Prior art keywords
strain
animal
use according
group
animals
Prior art date
Application number
DK05706458.6T
Other languages
English (en)
Inventor
Eric Nadeau
John Morris Fairbrother
Original Assignee
Prevtec Microbia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevtec Microbia Inc filed Critical Prevtec Microbia Inc
Application granted granted Critical
Publication of DK1715755T3 publication Critical patent/DK1715755T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/50—Feeding-stuffs specially adapted for particular animals for rodents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Claims (20)

1. Anvendelse af en virksom mængde af levende, ikke-patogen F4+Escherichia co//-stamme til at fremme vækst i et dyr eller til at homogenisere vækst hos en flok dyr, og hvor den levende, ikke-patogene F4+Escherichia co//-stamme anvendes oralt.
2. Anvendelse ifølge krav 1 til at fremme vækst i et dyr.
3. Anvendelse ifølge krav 1 til at homogenisere vækst hos en flok dyr.
4. Anvendelse ifølge krav 1, 2 eller 3, hvor den virksomme mængde af ikke-patogene F4+Escherichia co//-stamme er forbundet med en til fødemiddel acceptabel bærer.
5. Anvendelse ifølge krav 4, hvor dyret fodres med den ikke-patogene F4+Escherichia co//-stamme i forbindelse med en til et fast eller flydende fødemiddel acceptabel bærer.
6. Anvendelse ifølge krav 5, hvor den til fast føde acceptable bærer er et almindeligt fast fødemiddel.
7. Anvendelse ifølge krav 5, hvor den til væske acceptable bærer er vand.
8. Anvendelse ifølge krav 5, hvor den til væske acceptable bærer er mælk.
9. Anvendelse ifølge et af kravene 1 til 8, hvor den virksomme mængde er mindst ca. 5E7 CFU af ikke-patogen F4+Escherichia coii-stamme per dyr.
10. Anvendelse ifølge krav 9, hvor den virksomme mængde ligger i området fra ca. 5E7 til ca. 5E9 CFU af ikke-patogene F4+Escherichia co//-stamme per dyr.
11. Anvendelse ifølge et af kravene 1 til 10, hvor den ikke-patogene F4+Escherichia co//-stamme består af Escherichia co/Fstammen, som er deponeret hos International Depository Authority of Canada (IDAC) den 21. ja nuar 2005 under ansøgningsnummer IDAC 210105-01, sine mutanter eller varianter deraf.
12. Anvendelse ifølge et af kravene 1 til 11, hvor dyret eller dyrene er udvalgt fra gruppen bestående af et dyr efter afvænning og et dyr efter udklækning.
13. Anvendelse ifølge krav 12, hvor dyret efter afvænning er mellem ca. 10 og ca. 28 dage gammel.
14. Anvendelse ifølge krav 12, hvor dyret efter udklækning er mellem ca. 1 og ca. 7 dage gammel.
15. Anvendelse ifølge krav 12 eller 13, hvor dyret efter afvænning er et svin.
16. Anvendelse ifølge krav 12 eller 13, hvor dyret efter afvænning er en mus.
17. Anvendelse ifølge krav 12 eller 14, hvor dyret efter udklækning er fjerkræ.
18. Anvendelse ifølge krav 17, hvor fjerkræ er en kylling.
19. Ikke-patogen F4+Escherichia co//-stamme, som er deponeret hos International Depository Authority of Canada (IDAC) den 21. januar 2005 under ansøgningsnummer IDAC 210105-01.
20. Sammensætning omfattende den ikke-patogene F4+Escherichia coli-stamme ifølge krav 19.
DK05706458.6T 2004-02-03 2005-02-03 Anvendelse af levende bakterier til fremme af vækst i dyr DK1715755T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54105304P 2004-02-03 2004-02-03
PCT/CA2005/000138 WO2005074706A1 (en) 2004-02-03 2005-02-03 Use of live bacteria for growth promotion in animals

Publications (1)

Publication Number Publication Date
DK1715755T3 true DK1715755T3 (da) 2015-03-09

Family

ID=34837452

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05706458.6T DK1715755T3 (da) 2004-02-03 2005-02-03 Anvendelse af levende bakterier til fremme af vækst i dyr

Country Status (15)

Country Link
US (5) US7981411B2 (da)
EP (1) EP1715755B1 (da)
CN (2) CN1913787B (da)
AU (1) AU2005211140B2 (da)
BR (1) BRPI0507410B1 (da)
CA (1) CA2552811C (da)
DK (1) DK1715755T3 (da)
ES (1) ES2531971T3 (da)
HK (1) HK1099668A1 (da)
HU (1) HUE024565T2 (da)
PL (1) PL1715755T3 (da)
PT (1) PT1715755E (da)
RU (1) RU2403712C2 (da)
SI (1) SI1715755T1 (da)
WO (1) WO2005074706A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1715755T3 (pl) * 2004-02-03 2015-08-31 Prevtec Microbia Inc Stosowanie żywych bakterii do promowania wzrostu u zwierząt
US7935512B2 (en) 2006-05-01 2011-05-03 The University Of Manitoba Colicinogenic strain of E. coli
JP6278960B2 (ja) 2012-07-20 2018-02-14 プレヴテック マイクロビア インコーポレイテッド 非病原性ｆ１８ｅ．ｃｏｌｉ株及びその使用
JP6506173B2 (ja) 2012-11-23 2019-04-24 セレス セラピューティクス インコーポレイテッド 相乗的細菌組成物並びにその生成及び使用の方法
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
BR112015018625A2 (pt) 2013-02-04 2017-09-19 Seres Therapeutics Inc composições e métodos
US10973861B2 (en) 2013-02-04 2021-04-13 Seres Therapeutics, Inc. Compositions and methods
AU2014232370B2 (en) 2013-03-15 2018-11-01 Seres Therapeutics, Inc. Network-based microbial compositions and methods
EP3074027A1 (en) 2013-11-25 2016-10-05 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP3082431A4 (en) 2013-12-16 2017-11-15 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
WO2016127260A1 (en) * 2015-02-11 2016-08-18 Prevtec Microbia Inc Improved dry matrix for embedding viable escherichia coli, method of making same and use thereof
EP3468382A4 (en) * 2016-06-14 2020-01-22 Prevtec Microbia Inc FOOD GRANULES FOR ANIMALS COMPRISING A FOOD ADDITIVE, METHOD FOR MANUFACTURING AND USING THE SAME
AU2018318132A1 (en) 2017-08-14 2020-02-27 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
CN113749049B (zh) * 2021-10-19 2023-06-02 绵阳市农业科学研究院 提高后备母羊抗体水平的驯化方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761372A (en) 1981-01-12 1988-08-02 New York University Mutant enterotoxin of E. coli
NZ199866A (en) 1981-03-09 1984-11-09 Cetus Corp Vaccine for prevention of gastroenteric disease:non-pathogenic strain genetically engineered to comprise genes for adhesin and/or toxoids
US5137721A (en) * 1981-03-09 1992-08-11 Cetus Corporation Employing strains of E. coli expressing non-indigenous adhesins and toxoids of E. coli
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
EP1003451B1 (en) 1997-08-13 2004-06-30 Life Science Holdings, Inc. Brain cooling apparatus for cooling the brain
IL130303A0 (en) * 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use
PL1715755T3 (pl) * 2004-02-03 2015-08-31 Prevtec Microbia Inc Stosowanie żywych bakterii do promowania wzrostu u zwierząt
WO2007136553A2 (en) 2006-05-18 2007-11-29 Biobalance Llc Bacterial strains, compositions including same and probiotic use thereof

Also Published As

Publication number Publication date
US20160354415A1 (en) 2016-12-08
US9452188B2 (en) 2016-09-27
BRPI0507410A (pt) 2007-06-26
HUE024565T2 (hu) 2016-02-29
RU2006131574A (ru) 2008-03-10
CN103039712A (zh) 2013-04-17
US20110262410A1 (en) 2011-10-27
US20070218035A1 (en) 2007-09-20
US7981411B2 (en) 2011-07-19
EP1715755A4 (en) 2009-11-25
EP1715755B1 (en) 2014-12-17
EP1715755A1 (en) 2006-11-02
RU2403712C2 (ru) 2010-11-20
SI1715755T1 (sl) 2015-04-30
AU2005211140A1 (en) 2005-08-18
CA2552811A1 (en) 2005-08-18
CN1913787A (zh) 2007-02-14
US20140219977A1 (en) 2014-08-07
CA2552811C (en) 2016-11-08
WO2005074706A1 (en) 2005-08-18
BRPI0507410B1 (pt) 2020-11-03
HK1099668A1 (en) 2007-08-24
AU2005211140B2 (en) 2009-12-17
US20130129694A1 (en) 2013-05-23
PT1715755E (pt) 2015-03-16
CN1913787B (zh) 2014-11-26
ES2531971T3 (es) 2015-03-23
PL1715755T3 (pl) 2015-08-31
US8679823B2 (en) 2014-03-25
US9861665B2 (en) 2018-01-09
US8343751B2 (en) 2013-01-01

Similar Documents

Publication Publication Date Title
DK1715755T3 (da) Anvendelse af levende bakterier til fremme af vækst i dyr
Gharib et al. Comparison of the effects of probiotic, organic acid and medicinal plant on Campylobacter jejuni challenged broiler chickens
Mahmood et al. Non-antibiotic strategies for the control of necrotic enteritis in poultry
Vandeplas et al. Contamination of poultry flocks by the human pathogen Campylobacter spp. and strategies to reduce its prevalence at the farm level.
Moarrab et al. Effect of synbiotic on performance, intestinal morphology, fecal microbial population and blood metabolites of suckling lambs
Herich et al. Effect of preventive application of Enterococcus faecium EF55 on intestinal mucosa during salmonellosis in chickens
Kupryś-Caruk et al. Efficacy and safety assessment of microbiological feed additive for chicken broilers in tolerance studies
Nam et al. Effects of probiotic (Lactobacillus plantarum and Bacillus subtilis) supplementation on mortality, growth performance, and carcass characteristics of native Vietnamese broilers challenged with Salmonella Typhimurium
Kyriakis et al. Evaluation of Toyocerin, a probiotic containing Bacillus toyoi spores, on health status and productivity of weaned, growing and finishing pigs
Alonge et al. Comparing the effects of supplementary antibiotic, probiotic, and prebiotic on carcass composition, Salmonella counts and serotypes in droppings and intestine of broiler chickens.
Mushtaq et al. Immunomodulatory and hepato-protective role of water based supplemented Bacillus clausii in broiler chicks
Balevi et al. Effect of dietary probiotic on performance and humoral immune response in layer hens
Akbarimehr et al. Multi-strain probiotic improved feed conversion ratio and selected health indicators in Japanese quail
Al-Surrayai et al. Evaluation of the lactic acid bacteria based formulated probiotic product for poultry
BISWAS EFFECTS OF LOCALLY ISOLATED PROBIOTICS AS ALTERNATIVE TO ANTIBIOTIC ON GROWTH PERFORMANCE, HEMATOLOGICAL TRAITS AND CECAL MICROFLORA OF BROILER CHICKEN
Sausen et al. Use of organic acid blends to control spread of salmonella heidelberg in broilers
da Silva Sabo et al. Impact of Probiotics on Animal Health
Castañeda Bustillo Early administration of probiotics through in ovo inoculation and their impact on gut microflora, immune response, and growth performance of broiler chicks
van Be Nam et al. Effects of probiotic (Lactobacillus plantarum and Bacillus subtilis) supplementation on mortality, growth performance, and carcass characteristics of native Vietnamese broilers challenged with Salmonella typhimurium.
Bustillo Early Administration of Probiotics through in Ovo Inoculation and Their Impact on Gut Microflora, Immune Response, and Growth Performance of Broiler Chicks
Gyan The effect of Dfm (Re-3, Re-3 Plus And P3) on the growth performance, carcass characteristics, microbiological and haemato-biochemical indices of broiler chickens
WO2023043986A1 (en) In ovo vaccines in combination with probiotics
Halsey Salmonella typhimurium infection in broilers and its effects on gastrointestinal health and performance
Ghaderi-Joybari et al. Immune tissue development in pathogen challenged broiler chicks fed diet supplemented with probiotic (Bacillus subtilis).
Wali The Effects of Lactobacillus plantarum NCIMB 41607 on Salmonella infection and the microbial population in the gastrointestinal tract of the chicken